KRAS and cancer: Features of serrated (n = 7) and non-serrated (n = 4) cancers with high-level microsatellite instability with respect to cancer and family history, mutation status of KRAS/BRAF, MLH1/MSH2 immunohistochemistry, and hMLH1 methylation